United States v. John Hardimon

700 F.3d 940, 2012 U.S. App. LEXIS 22834, 2012 WL 5416460
CourtCourt of Appeals for the Seventh Circuit
DecidedNovember 7, 2012
Docket11-1821, 11-2515
StatusPublished
Cited by20 cases

This text of 700 F.3d 940 (United States v. John Hardimon) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. John Hardimon, 700 F.3d 940, 2012 U.S. App. LEXIS 22834, 2012 WL 5416460 (7th Cir. 2012).

Opinion

POSNER, Circuit Judge.

The defendant, a chiropractor, pleaded guilty to defrauding health insurers and to money laundering and was sentenced to 70 months in prison (the bottom of the applicable guidelines range) and to pay restitution' of almost $2 million. In his guilty plea he waived his right to appeal; but shortly after pleading guilty he moved to retract the plea on the ground that he had been taking psychotropic drugs that had clouded his mind and made his plea involuntary. The judge denied the motion, and the’s first appeal attacks the denial as erroneous. His second appeal, which is from the part of the sentence that orders restitution, is blocked by the appeal waiver if we uphold the judge’s ruling with respect to the guilty plea. The first appeal is not blocked because the waiver was part of the guilty plea agreement that the appeal seeks to set aside as having been involuntary. If the plea is set aside, the entire sentence will have to be vacated, thus including the order to pay restitution. If the plea is not set aside, the entire sentence will stand. So in no event will we have to consider the merits of the restitution order in this appellate proceeding.

At the guilty-plea hearing the judge asked the defendant whether he was “currently under the influence of any drugs, medicine, or alcohol,” and the defendant answered: “prescription medications.” The judge asked him whether “any of these medications affect your ability to think clearly,” and the defendant answered “no,” and also “no” to whether he had been “treated in the past- 60 days for any addictions to drugs, medicine or alcohol of any kind.” But he answered “yes” to the next question- — whether he’d been treated in the past 60 days for “any mental disorders, mental defects, or mental problems.” The judge asked him to explain, and he replied that he was taking medicines for “high anxiety, depression, adult attention hyperactivity disorder, and depression.” . At “therapeutic level?” the judge asked, and the. defendant said “I believe so, yes.” The judge asked the defendant whether he thought the drugs were working and he said, “I believe the ADHD [attention deficit hyperactivity disorder — the disorder that he called ‘adult attention hyperactivity disorder’] medicine makes me concentrate more. It does cause quite a bit of anxiety, so they have given me something else to help the anxiety a little bit, but it [the ADHD medicine] definitely increases my alertness.” In answer to further questions the defendant assured the judge that he was “thinking clearly,” “capable of making decisions, serious decisions,” such as pleading guilty to the 15-count information that the government had filed against him, and that he had no “physical conditions or *942 problems that affect” his “ability to think clearly.” The judge then proceeded with the usual questions in a plea hearing, received the usual answers, and accepted the plea of guilty.

Six weeks later the defendant moved to withdraw the plea, explaining that he had been taking Prozac to treat his mental illnesses but that a week after the plea hearing his primary-care physician had switched him to Lexapro and “almost immediately” he experienced “increased alertness, awareness and attentiveness” and realized that at the plea hearing he had been “incapable of understanding the true nature of the charges against him ... and the consequences of his plea.”

The district court conducted an evidentiary hearing. The defendant submitted the abstract of a medical study which states that Lexapro may be a more effective treatment for major depression than Prozac. Andrea Cipriani et al., “Eseitalopram Versus Other Antidepressive Agents for Depression,” The Cochrane Library, Oct. 7, 2009, http://onlinelibrary.wiley.com/ doi/10.1002/14651858.CD006532.pub2/ abstract (all web sites cited in this opinion were visited on Nov. 2, 2012). He also submitted an email from his psychiatrist saying that certain rare side effects of Prozac, including hallucinations, could affect a person’s “ability to think and make decisions.” Hallucinations are also a possible, though again a rare, side effect of Lexapro. “Drugs & Medications' — Lexapro,” WebMD, www.webmd.com/drugs/ drug-63990-Lexapro.aspx?pagenumber=6. The psychiatrist noted that in the past the defendant had reported having a “better response to Lexapro than Prozac ... in terms of ... more clear thoughts.” This is possible because although the drugs are very similar (both are SSRIs — selective serotonin reuptake inhibitors), people may react somewhat differently to them. Harvard Health Publications, “What Are The Real Risks of Antidepressants?” www. health.harvard.edu/newsweek/What_are_th e_reaLjrisks_of_antidepressants.htm; Mayo Clinic, “Selective Serotonin Reuptake Inhibitors (SSRIs),” www.mayoclinic. com/health/ssris/MH00066.

The judge denied the motion to withdraw the guilty plea, in part because the defendant had presented no evidence that switching from Prozac to Lexapro could have the dramatic effects he claimed it had, and in part because at the plea hearing he had been alert and responsive and exhibited no signs of confusion. He certainly had not been hallucinating.

He argues that the judge should have inquired more deeply at the plea hearing into the drugs he was taking — should have asked him how much of each drug he was taking and what “effects the medications [as distinct from the underlying mental illnesses] might have on [his] clear-headedness.” We don’t think that such an inquiry was required. United States v. Weathington, 507 F.3d 1068, 1073-74 (7th Cir. 2007); United States v. Rollins, 552 F.3d 739, 741-42 (8th Cir.2009); United States v. Lessner, 498 F.3d 185, 193-96 (3d Cir. 2007); United States v. Savinon-Acosta, 232 F.3d 265, 269 (1st Cir.2000); Miranda-Gonzalez v. United States, 181 F.3d 164 (1st Cir.1999). The judge had already asked him whether he could think clearly, and he had said he could, which implies that he didn’t think his medications were affecting his ability to think clearly. Not being a psychiatrist, the judge could not use dosage information to infer inability to think clearly. He would have had to require the attendance of the defendant’s psychiatrist at the plea hearing and question him about the dosages and their actual and possible consequences. If we imposed such a requirement we might create a situation in which a significant fraction of *943 criminal defendants are placed in detention for psychiatric evaluation before being allowed to plead guilty.

A judge is required to investigate the defendant’s mental state if there are indications at the plea hearing or later of an impairment that made him incompetent to plead. The fact that a defendant seems competent when answering the judge’s questions at the plea hearing should not be conclusive; mental diseases, or mental impairments brought on by psychotropic drugs, might alter the premises of a person’s thinking rather than the articulation of his thoughts or his outward appearance or manner.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Donald Stenson
Seventh Circuit, 2026
United States v. Boria
Second Circuit, 2026
Carnell v. United States
S.D. Illinois, 2025
United States v. Pejman Kamkarian
79 F.4th 889 (Seventh Circuit, 2023)
Alexander v. United States
S.D. Illinois, 2022
Duplessis v. United States
S.D. Illinois, 2022
Faulkner v. United States
S.D. Illinois, 2021
Hardimon v. United States
E.D. Missouri, 2021
Turner v. United States
S.D. Illinois, 2020
Staszak v. United States
S.D. Illinois, 2020
United States v. Todd Dyer
Seventh Circuit, 2018
Garren v. State
813 S.E.2d 704 (Supreme Court of South Carolina, 2018)
United States v. George Gasich
701 F. App'x 504 (Seventh Circuit, 2017)
United States v. Huey Carter
795 F.3d 947 (Ninth Circuit, 2015)
United States v. Carol Woodard
744 F.3d 488 (Seventh Circuit, 2014)
United States v. Caramadre
957 F. Supp. 2d 160 (D. Rhode Island, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
700 F.3d 940, 2012 U.S. App. LEXIS 22834, 2012 WL 5416460, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-john-hardimon-ca7-2012.